Genentech Inc. and Pfizer Inc. entered into a settlement agreement to end litigation over Pfizer's biosimilar to Herceptin (trastuzumab), two months before the user fee goal date for US FDA action on Pfizer's product.
The companies disclosed the agreement in a Dec. 4 filing with the US District Court for the District of...